Agile Therapeutics, Inc.: 10-Q filed 2014-08-14
What Agile Therapeutics, Inc. reported in its quarterly report filed 2014-08-14 (fiscal Q2 2014): 23 published measures, 59 facts as tagged in accession 0001104659-14-061061.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-14
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001104659-14-061061 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Agile Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 66,271,210 | USD | |
| At 2013-12-31 | 14,405,136 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 48,348,650 | USD | |
| At 2013-12-31 | -71,441,572 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 53,494,022 | USD | |
| At 2013-12-31 | 2,119,646 | USD | |
| At 2013-06-30 | 8,193,001 | USD | |
| At 2012-12-31 | 20,013,754 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 6,741 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 4,633,503 | USD | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -3,652,485 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 11,964,777 | USD | |
| At 2013-12-31 | 11,963,079 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 592,345 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 836,158 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -3,494,710 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -5,942,337 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -3,249,070 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -7,477,431 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 54,155,240 | USD | |
| At 2013-12-31 | 2,266,350 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 403,488 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 781,714 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 378,228 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 756,456 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 5,302,744 | USD | |
| At 2013-12-31 | 6,844,503 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,325,664 | USD | |
| At 2013-12-31 | 715,454 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 3,494,710 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 5,942,337 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 3,249,070 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 7,477,431 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 2,390,857 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,785,180 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 2,425,741 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 5,497,454 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 18,592,968 | shares | |
| At 2013-12-31 | 103,536 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 169,540,281 | USD | |
| At 2013-12-31 | 46,872,723 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 278,135 | USD | |
| At 2013-12-31 | 273,092 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 18,208 | USD | |
| At 2013-12-31 | 18,208 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 373,270 | USD | |
| At 2013-12-31 | 379,164 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 661,218 | USD | |
| At 2013-12-31 | 146,704 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -3,718,401 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -2,879,108 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -3,619,879 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -8,216,109 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 1,103,853 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,157,157 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 823,329 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,979,977 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 5,043 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 6,159 | USD | 181 |
Inspect the source
- Entity
- Agile Therapeutics, Inc. / CIK 0001261249
- Captured
- SEC response SHA-256
dfa60388e3d618cfe1a780836e21d55d8bef6ac848684cf8fd7d6373390ae6f6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001261249.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))